Cleveland Girl Completed Leukemia Treatment

Adelynn Taylor rang the hospital bell after two and a half years of care at Cleveland Clinic Children's.

Updated on Sept. 19, 2026 in Cancer

Gouache-painted illustration of a polished brass bell on a wooden hospital wall, symbolizing the end of a long medical journey. — Seven-year-old Adelynn Taylor marked the end of her cancer treatment at Cleveland Clinic Children's on July 13, 2026, after entering remission. AI Illustration. Upload story photo >

Seven-year-old Adelynn Taylor marked the end of her cancer treatment on July 13, 2026, at Cleveland Clinic Children's. She entered remission after fighting B-cell acute lymphoblastic leukemia since age 4.

Why it matters

The completion of treatment signifies a major milestone for young patients who undergo years of intensive chemotherapy and immunotherapy. Continuous monitoring remains a standard practice to ensure the leukemia does not return.

Adelynn Taylor underwent two and a half years of chemotherapy and immunotherapy following her diagnosis at age 4. Doctors will continue to monitor the 7-year-old to ensure the leukemia remains in remission.

The players

Adelynn Taylor

She is a 7-year-old patient who recently completed treatment for B-cell acute lymphoblastic leukemia.

Cleveland Clinic Children's

This is the medical facility where the patient received treatment and held her completion ceremony.

The details

Adelynn Taylor celebrated her recovery at the hospital by ringing a bell to signify the end of her care. She also marked the moment by cutting an Adelynn Strong bracelet from her father's wrist.

Adelynn Taylor was diagnosed with leukemia at age 4.
The treatment ended on July 13, 2026.

The Big Picture

This recovery reflects the successful application of the Cleveland Clinic Children's pediatric oncology protocols. The result follows the established pattern for treating pediatric acute lymphoblastic leukemia through sustained clinical intervention.

Families facing similar diagnoses can view this recovery as a milestone in the long-term management of childhood leukemia. The outcome underscores the necessity of consistent clinical monitoring after completing active therapy.

The takeaway

Completing a years-long treatment plan requires immense patience and support from both the patient and their family. Celebrating these milestones serves as an important psychological step in the transition back to daily life.